Medication info
Widenex Plus Tablet

Widenex Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Widus Pharmaceutical Co., Ltd.
Appearance
Oval film-coated tablet in light orange color
Packaging
4 tablets (4 tablets/PTP x 1)
Approval status
Active

MFDS item code 201604702 · Approved 2016.07.29 · Insurance code 660703020

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Ingredients

Manufacturer
Widus Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

Adults: Administer 1 tablet orally once weekly Older adults: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in older adults (60 years and older) are similar to those in younger people. Patients with renal impairment: No dose adjustment is necessary for patients with a creatinine clearance of 30ml/min or greater. This medicine is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30ml/min. Food interferes with the absorption of this medicine, so take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it while sitting or standing upright with plenty of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce the absorption of this medicine. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should also not lie down for at least 30 minutes after taking it. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic illnesses) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements; measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. Taking this medicine once weekly provides one week’s supply of vitamin D at 800 IU daily. If a patient forgets to take a dose on the scheduled day, take it on the day they remember. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

Children: The safety and efficacy in children and adolescents who are still growing have not been established.

Precautions

This medication may irritate the gastrointestinal mucosa, leading to adverse esophageal reactions such as esophagitis, esophageal ulcers, and esophageal erosion. Symptoms may include dysphagia, odynophagia, pain behind the sternum, and heartburn. If these symptoms occur, stop taking the medication immediately and consult a doctor. Take this medication with a sufficient amount of water, and do not lie down for at least 30 minutes after taking it, following the prescribed dosage method strictly. Do not administer to patients with esophageal motility disorders, hypocalcemia, or severe renal impairment. Additionally, patients with genetic issues such as lactose intolerance should also avoid this medication. Various adverse reactions may occur during use, such as gastrointestinal disorders, bone pain, joint pain, muscle pain, skin rash, respiratory symptoms, etc. Particularly, this medication has rare side effects of osteonecrosis of the jaw; if dental treatment is necessary, consulting a specialist is required. Calcium and vitamin D intake may need supplementation, and be cautious as concomitant use with drugs containing divalent cations such as calcium and magnesium may hinder absorption. Women who are pregnant or breastfeeding should consult a doctor before taking this medication, as it may affect the fetus. The safety and efficacy of this medication in children have not been established, so it is advisable not to use it. In the case of overdose, hypocalcemia may occur, so seek medical assistance immediately. Store this medication out of reach of children, and avoid transferring it to another container as this may cause a decrease in quality.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • perforation
  • hemorrhage
  • gastric ulcer
  • duodenitis
  • glossitis
  • decreased blood calcium
Show 93 more
  • decreased blood phosphorus
  • osteoporosis
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • petechiae
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • hypertonia
  • sensory disturbances
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • trauma-related injury
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myopathy
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • facial edema
  • hair loss
  • anosmia
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blistering
  • osteonecrosis of the jaw
  • hepatic dysfunction
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and humidity. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness and ensure its safe use.

Appearance and packaging

Appearance

Oval film-coated tablet in light orange color

Package unit

4 tablets (4 tablets/PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.